Growth Metrics

Oruka Therapeutics (ORKA) Free Cash Flow Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 24.91%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 20.11%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.71%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -10.65%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 31.42%
10 Oruka Therapeutics 3.04 Bn 2.65 Bn - -145.68%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -145.68%
Dec 31, 2025 -147.58%
Sep 30, 2025 -105.56%
Jun 30, 2025 -106.73%
Mar 31, 2025 -69.34%
Dec 31, 2024 -56.08%
Sep 30, 2024 -78.42%
Jun 30, 2024 -43.61%
Mar 31, 2024 68.21%
Dec 31, 2023 29.46%
Sep 30, 2023 5.88%
Jun 30, 2023 12.75%
Mar 31, 2023 1.89%
Dec 31, 2022 -8.80%
Sep 30, 2022 -41.22%
Jun 30, 2022 -30.13%
Mar 31, 2022 -40.03%
Dec 31, 2021 -54.51%
Sep 30, 2021 -45.84%
Jun 30, 2021 -18.23%
Mar 31, 2021 -19.39%
Dec 31, 2020 10.51%
Sep 30, 2020 20.43%
Jun 30, 2020 40.49%
Mar 31, 2020 27.01%
Dec 31, 2019 32.94%
Sep 30, 2019 38.11%
Jun 30, 2019 30.38%
Mar 31, 2019 26.12%
Dec 31, 2018 19.99%
Sep 30, 2018 13.07%
Jun 30, 2018 2.12%
Mar 31, 2018 0.46%
Dec 31, 2017 -30.40%
Sep 30, 2017 -24.15%
Jun 30, 2017 -41.15%
Mar 31, 2017 -5.62%
Dec 31, 2016 -27.04%
Sep 30, 2016 -30.42%
Jun 30, 2016 -53.04%
Mar 31, 2016 -71.28%
Dec 31, 2015 -57.59%
Sep 30, 2015 -45.84%
Jun 30, 2015 -35.00%
Mar 31, 2015 -23.44%
Dec 31, 2014 -14.71%
Sep 30, 2014 -7.41%
Jun 30, 2014 5.77%
Mar 31, 2014 -23.85%
Dec 31, 2013 -17.92%
Sep 30, 2013 5.70%